Global Medical REIT Future Growth
Future criteria checks 3/6
Global Medical REIT is forecast to grow earnings and revenue by 61.6% and 3.2% per annum respectively while EPS is expected to grow by 55% per annum.
Key information
61.6%
Earnings growth rate
55.0%
EPS growth rate
| Health Care REITs earnings growth | 22.4% |
| Revenue growth rate | 3.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 17 Dec 2024 |
Recent future growth updates
Recent updates
Global Medical REIT's Underwriting Is Demonstrated To Be Effective
Sep 24Global Medical REIT: Stability Across The Board, But More Is Needed To Be Bullish
Aug 11Global Medical: The Yield Is Not Too Good To Be True
Jun 26Global Medical: The 7.6% Preferred Yield Trumps The Common
May 23Global Medical REIT: Better Q1 Than Expected, But Still A Cautious Stance
May 09Global Medical REIT Offers A 9.3% Dividend Yield And 7.6% On The Preferreds
Mar 09Global Medical REIT: Nothing Promising After Q4 Results, Still A Hold
Feb 29Global Medical REIT: Patient In Stable Condition, Risk Priced In
Feb 02Global Medical REIT: A Hold Despite Improving Performance
Nov 21Global Medical: 7.7% Yielding Preferreds Are Expensive, A Look At Alternatives
Oct 16Global Medical REIT: Revisiting Dividend Assumption After Q2 Results
Sep 10Global Medical REIT: Higher For Longer Scenarios Will Stress The REIT
Aug 04Global Medical: The 9.5% Yield Appears Covered Despite Pressure From Interest Rates
Jun 29If EPS Growth Is Important To You, Global Medical REIT (NYSE:GMRE) Presents An Opportunity
Mar 13
Global Medical REIT: A Strong Buy At Attractive Valuations And 7.8% Dividend Yield
Jan 27Global Medical REIT: Brace For A Hawkish Fed
Dec 25Global Medical REIT GAAP EPS of $0.12
Nov 02Global Medical REIT: Passive Income Machine With Safe 10.8% Yield
Oct 21Global Medical REIT stock drops after BMO downgrades on elevated leverage
Oct 06Global Medical REIT Now Has A 9% Recession Resistant Yield
Sep 28Global Medical REIT declares $0.21 dividend
Sep 09Global Medical REIT: Significant Upside Potential, Along With A High Yielding Dividend
Aug 18Global Medical REIT: Market Dislocation From First To Worst, Opportunity Refreshed
Jun 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 151 | 8 | 94 | N/A | 5 |
| 12/31/2025 | 147 | 6 | 92 | N/A | 6 |
| 12/31/2024 | 139 | 0 | -1,444 | N/A | 5 |
| 9/30/2024 | 137 | -1 | 68 | 68 | N/A |
| 6/30/2024 | 138 | 0 | 68 | 68 | N/A |
| 3/31/2024 | 140 | 15 | 67 | 67 | N/A |
| 12/31/2023 | 141 | 15 | 68 | 68 | N/A |
| 9/30/2023 | 144 | 16 | 69 | 69 | N/A |
| 6/30/2023 | 144 | 21 | 70 | 70 | N/A |
| 3/31/2023 | 142 | 11 | 76 | 76 | N/A |
| 12/31/2022 | 137 | 13 | 77 | 77 | N/A |
| 9/30/2022 | 131 | 17 | 76 | 76 | N/A |
| 6/30/2022 | 126 | 12 | 76 | 76 | N/A |
| 3/31/2022 | 120 | 13 | 70 | 70 | N/A |
| 12/31/2021 | 116 | 12 | 69 | 69 | N/A |
| 9/30/2021 | 111 | 9 | 68 | 68 | N/A |
| 6/30/2021 | 106 | -5 | 44 | 44 | N/A |
| 3/31/2021 | 99 | -7 | 38 | 38 | N/A |
| 12/31/2020 | 94 | -8 | 35 | 35 | N/A |
| 9/30/2020 | 89 | -8 | 28 | 28 | N/A |
| 6/30/2020 | 82 | 3 | 44 | 44 | N/A |
| 3/31/2020 | 77 | 4 | 43 | 43 | N/A |
| 12/31/2019 | 71 | 3 | 36 | 36 | N/A |
| 9/30/2019 | 65 | 9 | 32 | 32 | N/A |
| 6/30/2019 | 60 | 9 | 27 | 27 | N/A |
| 3/31/2019 | 57 | 8 | 22 | 22 | N/A |
| 12/31/2018 | 53 | 8 | 25 | 25 | N/A |
| 9/30/2018 | 49 | 0 | 23 | 23 | N/A |
| 6/30/2018 | 43 | 1 | N/A | 22 | N/A |
| 3/31/2018 | 37 | 0 | N/A | 19 | N/A |
| 12/31/2017 | 30 | -2 | N/A | 13 | N/A |
| 9/30/2017 | 24 | -3 | N/A | 8 | N/A |
| 6/30/2017 | 17 | -6 | N/A | 3 | N/A |
| 3/31/2017 | 12 | -6 | N/A | 2 | N/A |
| 12/31/2016 | 8 | -6 | N/A | -2 | N/A |
| 9/30/2016 | 6 | -5 | N/A | -2 | N/A |
| 6/30/2016 | 4 | -4 | N/A | 0 | N/A |
| 3/31/2016 | 3 | -3 | N/A | -1 | N/A |
| 12/31/2015 | 2 | -2 | N/A | 0 | N/A |
| 9/30/2015 | 3 | -1 | N/A | 0 | N/A |
| 6/30/2015 | 3 | -1 | N/A | 1 | N/A |
| 3/31/2015 | 2 | -1 | N/A | 0 | N/A |
| 12/31/2014 | 2 | -1 | N/A | 0 | N/A |
| 11/30/2014 | 1 | -1 | N/A | 0 | N/A |
| 8/31/2014 | 0 | -1 | N/A | 0 | N/A |
| 5/31/2014 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GMRE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: GMRE is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GMRE is expected to become profitable in the next 3 years.
Revenue vs Market: GMRE's revenue (3.2% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: GMRE's revenue (3.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GMRE's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 23:03 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Global Medical REIT Inc. is covered by 21 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gaurav Mehta | Alliance Global Partners |
| David Rodgers | Baird |
| Amanda Sweitzer | Baird |